Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis

126Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

CD40 ligand (CD40L) is expressed on activated CD4+ T lymphocytes and at the activated platelet surface. A circulating soluble form of CD40L (sCD40L) is generated by the way of a proteolytic cleavage. We measured sCD40L in the plasma of either healthy subjects; patients with inflammatory disorders and low, normal, or high platelet count (reactive thrombocytosis); or patients with essential thrombocythemia (ET). A tight correlation was found between the platelet count and plasma sCD40L. ET patients had the highest levels of sCD40L. Platelet-associated CD40L was increased in ET and reactive thrombocytosis, conditions associated with increased platelet regeneration. Platelet-associated CD40L was released upon platelet activation. In conclusion, platelets appear as a reservoir of CD40L that may be a major contributor to circulating sCD40L. Platelet-associated CD40L may be a potential marker of platelet regeneration. © 2002 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Viallard, J. F., Solanilla, A., Gauthier, B., Contin, C., Déchanet, J., Grosset, C., … Ripoche, J. (2002). Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis. Blood, 99(7), 2612–2614. https://doi.org/10.1182/blood.V99.7.2612

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free